Alterations in peripheral T cell subsets, T cell activation markers and immune checkpoint molecules in advanced pancreatic cancer patients receiving FOLFIRINOX or gemcitabine + nab-paclitaxel
Sams, L.E., Kruger, S., Heinemann, V., Bararia, D., Haebe, S., Alig, S., Westphalen, B., Haas, M., Kirchner, T., Ormanns, S., Endres, S., Weigert, O., von Bergwelt-Baildon, M., Kobold, S., Rataj, F., Boeck, S.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article